Skip to main content
Equibles

MANKIND · Mankind Pharma Limited

Use MANKIND with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research MANKIND.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
2,638.60 INR -21.40 (-0.80%) At close · Nov 12
Rebalance outlook locked
Market Cap
1.09T INR
Shares
413.05M
Volume · Nov 12 424.11K Avg daily vol (3M) 567.51K

Price & Indicators

Drag to pan · scroll to zoom
Indicators
Price
Panels
Event markers
20d MA 50d MA 200d MA Earnings Investor day
Close2,638.60 INR Open2,660.00 INR Day2,631.20–2,667.90 INR 52W close1,927.40–2,668.30 INR Avg vol 30d709K Last earningsOct 26, 2026 DataMay 2023–Nov 2026

Latest documents

2026
Oct 26
Earnings call
Q2 2027 earnings call

Mankind Pharma’s Q2 FY27 revenue was Rs. 4,338 crores, up 17.3% year-on-year; PAT reached Rs. 716 crores and EBITDA margin was 27.1%. International revenue grew 33% to Rs. 680 crores, while net debt was Rs. 2,639 crores.

All documents

Quarterly results

Revenue Net income Net loss
▲23.9% 32.30B INR 3.80B INR '25 Q3 ▲23.2% 30.08B INR 4.16B INR '25 Q4* ▲23.4% 35.70B INR 4.38B INR '26 Q1 ▲20.2% 36.97B INR 5.12B INR '26 Q2 ▲10.4% 35.67B INR 4.09B INR '26 Q3 ▲14.5% 34.43B INR 5.54B INR '26 Q4 ▲12.9% 40.31B INR 5.74B INR '27 Q1 LATEST ▲17.3% 43.38B INR 7.11B INR '27 Q2

* Q4 derived as the full year minus Q1 to Q3.

Technicals

trend & momentum for long-term holders illustrative — not investment advice
Price context
position in its 52-week range
Range low 1,927.40 INR Now 2,638.60 INR · 96% Range high 2,668.30 INR
vs 200-day avg +13% vs 50-day avg +9%

Illustrative technical + ownership context — a signal mix, not investment advice.

Performance

5D 20D 120D MTD YTD
XNSE:MANKIND +4.8% +13.0% +5.0% +5.9% +20.1%

Exchange listing

Market
XNSE
Ticker
MANKIND
ISIN
INE634S01028
Security
Ordinary share
Trading currency
INR

Company

Website
https://www.mankindpharma.com/
Investor relations
https://www.mankindpharma.com/investors-relations/disclosure-under-regulation-46-of-sebi-lodr/

Other listings of this company

Share classes and depositary receipts can have different prices and dividends.

Recent dividends

Ex-dividend dateAmount per share
2025-08-08 1.00 INR

Upcoming investor events

No upcoming investor events are listed for this company yet.

Earnings calls

  • Earnings call · Q2 2027 2026-10-26 Audio Transcript
    Earnings Call
  • Earnings call · Q1 2027 2026-07-30 Audio Transcript
    Earnings Call
  • Earnings call · Q4 2026 2026-05-20 Audio Transcript
    Earnings Call